Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Cancer Thrives by Evading Cell Death — Cattle Cells Could Help Researchers Fight Back

Learn more about apoptosis' role in cancer and how finding the best animal model to test cancer drugs may lead us to cows.

Cancer Thrives by Evading Cell Death — Cattle Cells Could Help Researchers Fight Back

Cancer cells manage to survive and thrive by evading a critical process called apoptosis, where healthy cells self-destruct to eliminate genetic errors. This newfound understanding of apoptosis's role in cancer has led researchers to seek better animal models for testing cancer drugs. Leipzig University researchers claim that bovine (cow) cells may be a more suitable model for studying cancer drugs because cow cells more closely resemble human cells in their apoptosis processes than previous gold-standard mouse cells.

This discovery could help prevent misleading results early in drug development, potentially saving time and resources. The researchers compared human blood samples with cells and tissues from mice, cattle, sheep, and pigs, focusing on BAX and BAK proteins essential for mitochondrial apoptosis. They found that BAX and BAK behaved very similarly between bovine and human cells, making bovine liver cells a promising alternative for testing anticancer medications.

By refining drug development in the early stages, researchers can better predict a drug's effects and side effects, ultimately improving patient outcomes. However, the study's authors plan to investigate how far the similarities between cattle and human cells extend, examining other cell types and anti-cancer compounds to better understand bovine cells' capabilities and limitations for future cancer drug research.

Written by urgent.news from Discover Magazine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at discovermagazine.com →

More in Health & Medicine

Reforms to the PhD?

The Trump administration is pairing top universities with corporate giants in an effort to steer traditional PhD programs toward national scientific priorities.

  • $47 million pilot program aims to modernize traditional PhD programs.
  • 31 universities and 20+ companies collaborate, with NSF funding three years per participant.

More from Wednesday 29 July →